As part of the ENTRY-DM network—an ambitious European research programme focused on advancing antisense oligonucleotide (ASO) therapies for Myotonic Dystrophy (DM)—a PhD position is now open in France.
ENTRY-DM will recruit 14 full-time doctoral candidates across Europe, each contributing to different aspects of translational DM research.
One of these positions will investigate the cognitive mechanisms of decision-making in DM1 patients, particularly in the context of participation in clinical trials.
Key information:
-
Research focus: Decision-making cognition in DM1 and its influence on clinical trial enrolment
-
Location: France
-
Language requirements: Fluency in both English and French (patient interaction required)
-
Candidate profile:
-
Master’s degree in neuropsychology, psychological sciences, or neurosciences
-
Must not have resided or carried out their main activity in France for more than 12 months in the past 3 years before recruitment
-
-
Expected start: 2025
-
Application deadline: 30 May 2025
This position offers a unique opportunity to contribute to impactful, patient-oriented research in an international and interdisciplinary environment.